Cagrilintide 5mg
Long-acting amylin analogue research compound for appetite control and metabolic health investigation.
What is CAGRI?
Cagrilintide is a long-acting amylin analogue developed for research into appetite regulation and metabolic health. Amylin is a peptide hormone co-secreted with insulin from pancreatic beta cells, playing a key role in postprandial glucose regulation and satiety signalling. Cagrilintide is modified for extended half-life, making it a valuable tool for sustained amylin receptor research.
Key Features
- Long-acting amylin analogue for sustained studies
- Selective amylin receptor agonist profile
- Complements GLP-1 research programmes
- High purity ≥98% verified by mass spectrometry
Mechanism of Action
Cagrilintide acts on amylin receptors (AMY1–3), which are formed by the calcitonin receptor combined with receptor activity-modifying proteins (RAMPs). Amylin receptor activation slows gastric emptying, suppresses glucagon secretion, and promotes satiety through central nervous system pathways. The long-acting modification allows researchers to study sustained amylin receptor activation.
Research Applications
- Amylin receptor pharmacology and signalling
- Satiety and appetite regulation pathway studies
- Gastric emptying and postprandial glucose research
- Glucagon suppression mechanism investigation
- Long-acting amylin analogue pharmacokinetics
- Metabolic syndrome pathway research
Reconstitution Guide
Reconstitute with sterile bacteriostatic water. Store at 2–8°C after reconstitution and use within 28 days.
Research Use Only. For research use only. Not for human or veterinary use. All products are intended solely for in vitro research and laboratory use. Helix Biotech does not endorse, encourage, or condone the use of any research compounds in humans or animals.
Research Tools
Related Products
View all
RETA20 — Retatrutide 20mg
Triple receptor agonist targeting GLP-1, GIP, and glucagon receptors for advanced metabolic research.
MS40 — MOTS-C
Mitochondria-derived peptide for advanced metabolic and cellular energy research.
NJ250 — NAD+ 250mg
Nicotinamide Adenine Dinucleotide — 250mg cellular energy and longevity research compound.